Stay updated on Baricitinib in Adult Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Baricitinib in Adult Atopic Dermatitis Clinical Trial page.

Latest updates to the Baricitinib in Adult Atopic Dermatitis Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision: v3.5.0 added; Revision: v3.4.3 removed.SummaryDifference0.0%

- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedThe page now displays Revision: v3.4.3, replacing Revision: v3.4.2.SummaryDifference0.0%

- Check57 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2 on the page. No substantive changes to study details, eligibility criteria, or locations were observed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check65 days agoChange DetectedRevision: v3.4.1 replaces the previous v3.4.0 revision. This is a metadata update that does not change study content or results.SummaryDifference0.0%

- Check66 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1 on the site. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check73 days agoChange DetectedNew UI and metadata elements were introduced: a 'Show glossary' toggle, the label 'Last Update Submitted that Met QC Criteria', the 'No FEAR Act Data' entry, and a revision note 'Revision: v3.4.0'. The previous wording and revision reference 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.SummaryDifference0.1%

Stay in the know with updates to Baricitinib in Adult Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Baricitinib in Adult Atopic Dermatitis Clinical Trial page.